featured
Tumor Mutational Burden and Immune Infiltration as Independent Predictors of Response to Neoadjuvant Immune Checkpoint Inhibition in Early TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor Mutational Burden and Immune Infiltration as Independent Predictors of Response to Neoadjuvant Immune Checkpoint Inhibition in Early TNBC in GeparNuevo
Ann. Oncol 2020 May 24;[EPub Ahead of Print], T Karn, C Denkert, KE Weber, U Holtrich, C Hanusch, BV Sinn, BW Higgs, P Jank, HP Sinn, J Huober, C Becker, JU Blohmer, F Marmé, WD Schmitt, S Wu, M van Mackelenbergh, V Müller, C Schem, E Stickeler, PA Fasching, C Jackisch, M Untch, A Schneeweiss, S LoiblFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.